These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice. Kakizoe E, Shiota N, Tanabe Y, Shimoura K, Kobayashi Y, Okunishi H. J Invest Dermatol; 2001 Jan; 116(1):118-23. PubMed ID: 11168806 [Abstract] [Full Text] [Related]
3. Mast cell accumulation and cytokine expression in the tight skin mouse model of scleroderma. Wang HW, Tedla N, Hunt JE, Wakefield D, McNeil HP. Exp Dermatol; 2005 Apr; 14(4):295-302. PubMed ID: 15810888 [Abstract] [Full Text] [Related]
4. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K. J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379 [Abstract] [Full Text] [Related]
5. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis. Yoshizaki A, Yanaba K, Yoshizaki A, Iwata Y, Komura K, Ogawa F, Takenaka M, Shimizu K, Asano Y, Hasegawa M, Fujimoto M, Sato S. Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342 [Abstract] [Full Text] [Related]
6. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats. Kanemitsu H, Takai S, Tsuneyoshi H, Nishina T, Yoshikawa K, Miyazaki M, Ikeda T, Komeda M. Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654 [Abstract] [Full Text] [Related]
7. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis. Howard PS, Renfrow D, Schechter NM, Kucich U. Neurourol Urodyn; 2004 Jan; 23(4):374-82. PubMed ID: 15227657 [Abstract] [Full Text] [Related]
8. Chymase inhibitor improves dermatitis in NC/Nga mice. Watanabe N, Tomimori Y, Saito K, Miura K, Wada A, Tsudzuki M, Fukuda Y. Int Arch Allergy Immunol; 2002 Jul; 128(3):229-34. PubMed ID: 12119505 [Abstract] [Full Text] [Related]
9. Chymase inhibitor ameliorates eosinophilia in mice infected with Nippostrongylus brasiliensis. Watanabe N, Miura K, Fukuda Y. Int Arch Allergy Immunol; 2002 Jul; 128(3):235-9. PubMed ID: 12119506 [Abstract] [Full Text] [Related]
10. Mast cell chymase inhibits smooth muscle cell growth and collagen expression in vitro: transforming growth factor-beta1-dependent and -independent effects. Wang Y, Shiota N, Leskinen MJ, Lindstedt KA, Kovanen PT. Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1928-33. PubMed ID: 11742866 [Abstract] [Full Text] [Related]
11. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M. Circulation; 2003 May 27; 107(20):2555-8. PubMed ID: 12742989 [Abstract] [Full Text] [Related]
12. Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma. Iwasaki T, Imado T, Kitano S, Sano H. Arthritis Res Ther; 2006 May 27; 8(6):R161. PubMed ID: 17049072 [Abstract] [Full Text] [Related]
13. The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy. Riekki R, Harvima IT, Jukkola A, Risteli J, Oikarinen A. Exp Dermatol; 2004 Jun 27; 13(6):364-71. PubMed ID: 15186323 [Abstract] [Full Text] [Related]
14. Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction. Beghdadi W, Madjene LC, Claver J, Pejler G, Beaudoin L, Lehuen A, Daugas E, Blank U. Kidney Int; 2013 Aug 27; 84(2):317-26. PubMed ID: 23515052 [Abstract] [Full Text] [Related]
15. Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs. Jin D, Ueda H, Takai S, Okamoto Y, Muramatsu M, Sakaguchi M, Shibahara N, Katsuoka Y, Miyazaki M. J Am Soc Nephrol; 2005 Apr 27; 16(4):1024-34. PubMed ID: 15744002 [Abstract] [Full Text] [Related]
16. Transforming growth factor-beta 1 and collagen gene expression during postnatal skin development and fibrosis in the tight-skin mouse. Pablos JL, Everett ET, Harley R, LeRoy EC, Norris JS. Lab Invest; 1995 Jun 27; 72(6):670-8. PubMed ID: 7783425 [Abstract] [Full Text] [Related]
17. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection. Kaminska R, Harvima IT, Naukkarinen A, Nilsson G, Horsmanheimo M. J Pathol; 1996 Dec 27; 180(4):434-40. PubMed ID: 9014866 [Abstract] [Full Text] [Related]
18. Vascular chymase: pathophysiological role and therapeutic potential of inhibition. Doggrell SA, Wanstall JC. Cardiovasc Res; 2004 Mar 01; 61(4):653-62. PubMed ID: 14985062 [Abstract] [Full Text] [Related]
19. Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta. Uehara Y, Urata H, Ideishi M, Arakawa K, Saku K. Cardiovasc Res; 2002 Sep 01; 55(4):870-6. PubMed ID: 12176136 [Abstract] [Full Text] [Related]
20. The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice. Takato H, Yasui M, Ichikawa Y, Waseda Y, Inuzuka K, Nishizawa Y, Tagami A, Fujimura M, Nakao S. Exp Lung Res; 2011 Mar 01; 37(2):101-8. PubMed ID: 21128860 [Abstract] [Full Text] [Related] Page: [Next] [New Search]